Anne Le Bouter
Impact in
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Antimicrobial Resistance in Staphylococcus
-
- Antibiotic Resistance in Bacteria
Papers in
-
- SARS-CoV-2 and COVID-19 Research 3
- Antimicrobial Resistance in Staphylococcus 2
- COVID-19 Clinical Research Studies 1
- SARS-CoV-2 detection and testing 1
-
- Influenza Virus Research Studies 1
- Co-authors
- Slim Fourati (5 shared papers)Vincent Cattoir (1 shared paper)Roland Leclercq (1 shared paper)Sébastien Maury (2 shared papers)Rabah Redjoul (2 shared papers)Petra van der Groep (1 shared paper)Fred H. Menko (1 shared paper)René H.M. Verheijen (1 shared paper)
- Journals
- Journal of Hematology & Oncology (1 paper)Journal of Clinical Pathology (1 paper)Clinical Microbiology and Infection (1 paper)International Journal of Infectious Diseases (1 paper)International Journal of Antimicrobial Agents (1 paper)
- Partner nations
- FranceNetherlandsUnited States
In The Last Decade
Anne Le Bouter
9 papers receiving 194 citations
Peers
Comparison fields: 5 of 45
- Infectious Diseases 97
- Molecular Medicine 13
- Oncology 46
- Cancer Research 24
- Clinical Biochemistry 10
Countries citing papers authored by Anne Le Bouter
This map shows the geographic impact of Anne Le Bouter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Le Bouter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Le Bouter more than expected).
Fields of papers citing papers by Anne Le Bouter
This network shows the impact of papers produced by Anne Le Bouter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Le Bouter. The network helps show where Anne Le Bouter may publish in the future.
Co-authors
The 25 scholars most cited alongside Anne Le Bouter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 74 | |
| 2 | 2021 | 50 | |
| 3 | 2010 | 34 | |
| 4 | 2012 | 15 | |
| 5 | 2022 | 10 | |
| 6 | 2022 | 10 | |
| 7 | 2021 | 7 | |
| 8 | 2024 | 1 | |
| 9 | 2011 | 1 |
About Anne Le Bouter
Anne Le Bouter is a scholar working on Infectious Diseases, Epidemiology, Ophthalmology, Obstetrics and Gynecology and Molecular Medicine, having authored 9 papers that have together received 202 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), Antimicrobial Resistance in Staphylococcus (2 papers), COVID-19 Impact on Reproduction (1 paper), COVID-19 Clinical Research Studies (1 paper), Ocular Infections and Treatments (1 paper), SARS-CoV-2 detection and testing (1 paper), Influenza Virus Research Studies (1 paper) and BRCA gene mutations in cancer (1 paper). The work is most often cited by research in Infectious Diseases (97 citations), Molecular Medicine (13 citations), Oncology (46 citations), Cancer Research (24 citations) and Clinical Biochemistry (10 citations). Anne Le Bouter has collaborated with scholars based in France, Netherlands and United States. Frequent co-authors include Slim Fourati, Vincent Cattoir, Roland Leclercq, Sébastien Maury, Rabah Redjoul, Petra van der Groep, Fred H. Menko, René H.M. Verheijen, Elsken van der Wall and Ivar Siccama. Their work appears in journals such as Journal of Hematology & Oncology, Journal of Clinical Pathology, Clinical Microbiology and Infection, International Journal of Infectious Diseases and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.